Use of Patiromer to transition chronic kidney disease patients with hyperkalemia to a plant-rich diet.

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Chronic Kidney Disease, Stages 3b-4
    Mild Hyperkalemia (potassium 5.1 To
  • Age: Between 19 years - 80 years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Stages 3B-4 CKD
    2. No prior treatment with patiromer
    3. Mild hyperkalemia (potassium 5.1 to 6.5 mEq/L) on one of the last two blood tests
    4. No prior episodes of moderate-severe hyperkalemia (potassium >6.5 mEq/L)
    5. Deemed appropriate for the intervention by the your nephrologist

You may not be eligible for this study if the following are true:

    1. Recent change in medications that affect blood potassium concentrations
    2. Diagnosed with bowel diseases or syndromes (e.g., bowel obstruction, major GI surgery, short-bowel syndrome, irritable bowel syndrome, inflammatory bowel disease, chronic diarrhea)
    3. Diagnosed with swallowing disorders
    4. Unable to separate patiromer dose from other medications by 6 hours
    5. Dietary restrictions (e.g., allergies) or otherwise unable/unwilling to adhere to study diets (excludes dietary restrictions on high-potassium foods)
    6. Pregnant (females) or planning to become pregnant (males and females) during the study



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.